Cardiac Magnetic Resonance for Diagnosis and Risk Stratification

Abdallah Sanaani; Anthon Fuisz

doi:10.1016/j.ccl.2018.08.002

Cardiac Magnetic Resonance for Diagnosis and Risk Stratification

Cardiol Clin. 2019 Feb;37(1):27-33. doi: 10.1016/j.ccl.2018.08.002. Epub 2018 Sep 26.

Authors

Abdallah Sanaani¹, Anthon Fuisz²

Affiliations

¹ Gunderson Health System, La Crosse Campus, 1900 South Avenue, La Crosse, WI 54601, USA.
² Westchester Medical Center, 100 Woods Road, Macy 132, Valhalla, NY 10595, USA. Electronic address: anthon.fuisz@wmchealth.org.

PMID: 30447713
DOI: 10.1016/j.ccl.2018.08.002

Abstract

Cardiac MRI (CMR) is an essential tool for the evaluation of the patient with hypertrophic cardiomyopathy (HCM). First, the accurate morphologic imaging and measures that are possible with CMR help to ascertain the diagnosis. Second, the tissue characterization that can be done with MRI helps to define the abnormalities in the myocardium and to identify areas of fibrosis that have been linked to increase risk of sudden cardiac death and heart failure. In addition, CMR can help distinguish HCM from similar disease processes.

Keywords: Cardiac MRI; Hypertrophic cardiomyopathy; Imaging.

Publication types

Review

MeSH terms

Cardiomyopathy, Hypertrophic / pathology*
Contrast Media
Fibrosis / pathology
Gadolinium
Humans
Magnetic Resonance Angiography*
Mitral Valve Insufficiency / pathology
Myocardial Perfusion Imaging / methods
Myocardium / pathology
Risk Factors
Ventricular Dysfunction, Left / pathology
Ventricular Outflow Obstruction / pathology

Substances

Contrast Media
Gadolinium